|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02053779 |
|
Date of registration:
|
31/01/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT
GTMLPSGI |
|
Scientific title:
|
The Impact of a Single Dose of GnRH Agonist (Triptorelin 0,1 mg) at the Time of Implantation on the Reproductive Outcome in IVF Cycles Triggered by a GnRH Agonist Followed by a Small Bolus of HCG the Day of Oocyte Retrieval |
|
Date of first enrolment:
|
March 2014 |
|
Target sample size:
|
328 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02053779 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Algeria
| | | | | | | |
|
Contacts
|
|
Name:
|
Abdelhamid benmachiche, Doctor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Ibn roch infertility centre, cité boussouf, Constantine Algeria |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Female age < 40 years
- Baseline FSH and LH < 12 IU/l.
- Body Mass Index > 18 and < 35 kg/m2
- No uterine (fibroids, mullerian malformations), ovarian ( endometrioma) or adnexa
(hydrosalpinx) abnormalities
- Patients with at least one embryo at transfer time
Exclusion Criteria:
- Very high risk of OHSS (> 30 follicles > 12 mm the day of ovulation triggering).
- Reduced ovarian reserve
- Fertilization failure
- Severe endocrinopathy
- Azoospermia
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Infertility
|
|
Intervention(s)
|
|
Drug: Triptorelin 0.1mg
|
|
Primary Outcome(s)
|
|
implantation rate
[Time Frame: 5 weeks after IVF/ICSI]
|
|
Secondary Outcome(s)
|
|
clinical pregnancy
[Time Frame: 5 weeks after IVF/ICSI]
|
|
chemical pregnancy
[Time Frame: 2 weeks after IVF/ICSI]
|
|
live birth
[Time Frame: 26 weeks after IVF/ICSI]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|